(S)-2-Amino-4-cyclohexylbutyric acid hydrochloride is a chiral, non-proteinogenic amino acid derivative. It features a cyclohexyl group attached to a butyric acid backbone, with an amino group at the alpha position. The compound is provided as the hydrochloride salt, enhancing its stability and solubility for synthetic applications. This compound serves as a crucial chiral building block in pharmaceutical research and development. Its primary application is as a key intermediate in the synthesis of peptide-based drugs and peptidomimetics. The cyclohexyl side chain contributes to lipophilicity and can influence the conformational properties and receptor binding affinity of the final bioactive molecule. It is particularly valuable for introducing structural diversity and modulating the pharmacokinetic profiles of therapeutic candidates. As a protected amino acid derivative, it is readily incorporated into peptide sequences using standard solid-phase or solution-phase peptide synthesis techniques. The (S)-configuration at the alpha carbon is essential for maintaining the desired stereochemistry in the final product, which is critical for biological activity in many drug candidates targeting proteases, receptors, or other biological macromolecules.